Cargando…
Cystatin C proteoforms in chronic kidney disease
Cystatin C, a cysteine protease inhibitor, is used as a biomarker of renal function. It offers several advantages compared to creatinine, and formulas for the estimation of the glomerular filtration rate based on cystatin C have been developed. Recently, several proteoforms of cystatin C have been d...
Autores principales: | Dahl, Helene, Meyer, Klaus, Sandnes, Kristina, Welland, Natasha Lervaag, Arnesen, Iselin, Marti, Hans-Peter, Dierkes, Jutta, Lysne, Vegard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891521/ https://www.ncbi.nlm.nih.gov/pubmed/36724153 http://dx.doi.org/10.1371/journal.pone.0269436 |
Ejemplares similares
-
High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study
por: Dierkes, Jutta, et al.
Publicado: (2018) -
Correction to: High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study
por: Dierkes, Jutta, et al.
Publicado: (2018) -
The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
por: Yassine, Hussein N., et al.
Publicado: (2016) -
The Association of Sarcopenia and Central Obesity with Mortality Risk in Patients with Chronic Kidney Disease – a 2-Year Observational Study
por: Dahl, Helene, et al.
Publicado: (2022) -
Food Sources Contributing to Intake of Choline and Individual Choline Forms in a Norwegian Cohort of Patients With Stable Angina Pectoris
por: Van Parys, Anthea, et al.
Publicado: (2021)